Assessment of vascular invasion in pancreatic carcinoma by MDCT  by Hassanen, Omar et al.
The Egyptian Journal of Radiology and Nuclear Medicine (2014) 45, 271–277Egyptian Society of Radiology and Nuclear Medicine
The Egyptian Journal of Radiology andNuclearMedicine
www.elsevier.com/locate/ejrnm
www.sciencedirect.comORIGINAL ARTICLEAssessment of vascular invasion
in pancreatic carcinoma by MDCT* Corresponding author. Tel.: +20 1288176817; fax: +20 403333893.
E-mail address: mohamed.eltomey@med.tanta.edu.eg (M.A. Eltomey).
Peer review under responsibility of Egyptian Society of Radiology and
Nuclear Medicine.
Production and hosting by Elsevier
0378-603X  2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear Medicine.
http://dx.doi.org/10.1016/j.ejrnm.2014.02.009Open access under CC BY-NC-ND license.Omar Hassanen, Usama Ghieda, Mohamed A. Eltomey *Radiology & Medical Imaging Department, Faculty of Medicine, Tanta University, EgyptReceived 27 December 2013; accepted 12 February 2014
Available online 27 March 2014KEYWORDS
Pancreatic;
Carcinoma;
Vascular invasion;
Computed tomographyAbstract Background: Pancreatic cancer is one of the aggressive cancers with poor resectability
and survival rates. The relationship to adjacent vessels must be assessed before deciding the choice
of treatment.
Aim: Assessment of the MDCT signs of arterial and venous invasion in pancreatic carcinoma.
Subjects and methods: Total of 179 of the major peripancreatic vessels (CA; CHA; SMA; PV;
SMV) in 47 patients who underwent surgery for pancreatic cancer after MDCT were assessed at
surgery and compared with CT ﬁndings. Statistical analysis of the ﬁndings was done using Chi
square test.
Results: 115 vessels were not invaded at surgery, while the remaining 64 vessels were invaded (22
arteries and 42 veins). There was over all statistically signiﬁcant difference between arterial and
venous invasion regarding stenosis, occlusion, inﬁltration and circumferential involvement of the
vessel wall.
Conclusion: Assessment of vascular invasion is crucial in the evaluation of resectability for pancre-
atic cancer. MDCT is an accurate diagnostic tool for peripancreatic vascular invasion in cancer
pancreas.
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.1. Introduction
Pancreatic cancer is considered one of the most deadly and
aggressive cancers. The resectability and 5-year survival rates
for pancreatic cancer are still very poor with survival rates
for cancers of the pancreatic body and tail about 10% & that
for pancreatic head about 19% (1–4). The complication rates
of pancreatic surgery are approximately 40%. It is therefore
crucial to correctly identify patients who would most beneﬁt
from surgery i.e., those with lesions potentially responsive to
curative resection, and reduce as much as possible the number
of unnecessary laparotomies (5). In addition to diagnosing and
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to major peripancreatic vessels, including celiac artery (CA);
common hepatic artery (CHA); superior mesenteric artery
(SMA); portal vein (PV); superior mesenteric vein (SMV) must
be thoroughly assessed, since their involvement can preclude
resection (6). CT is the established method for diagnosing
and staging pancreatic carcinoma (7,8). The introduction of
MDCT has allowed further reﬁnements in detecting pancreatic
adenocarcinoma and in determining unresectability (8–11).
Multi-detector row CT (MDCT) scanning of the pancreas en-
ables multiphasic thin collimation scanning, with excellent spa-
tial resolution, especially in the z-plane (9). These volume data
sets can be easily manipulated with three-dimensional imaging,
potentially providing additional information to conventional
axial scans (12).
2. Aim of work
The purpose of our study was to assess the MDCT signs of
arterial and venous invasion in pancreatic carcinoma.
3. Patients and methods
Between October 2010 and March 2013, 112 consecutive pa-
tients with suspected pancreatic carcinoma underwent biphasic
MDCT for pancreatic examination.
3.1. Examination techniques
The following multi-detector CT scanners were used to exam-
ine the patients: (TOSHIBA Aquilion 16, Toshiba Medical sys-
tems, Japan) for 82 patients, and (Siemens Emotion 16;
Siemens, Erlangen, Germany) for 30 patients, 600–800 ml of
water or water soluble contrast agent was given orally to pa-
tients prior to the study to distend stomach, duodenum &
proximal jejunum. Each patient received 100 ml of non-ionic
contrast material (iopromide 370 mg/ml; Ultravist; Schering,
Berlin, Germany) via intravenous injection at the rate of
4 ml/s. Unenhanced and biphasic, late arterial phase and por-
tal venous phase, enhanced scans were performed. We rou-
tinely use bolus tracking, positioning a region of interest on
the abdominal aorta at the level of the celiac axis and using
an enhancement threshold of 110 HU, late arterial phase (10-
s delay from the time of peak aortic enhancement), and a por-
tal venous phase (35-s delay).
The CT examinations were performed in the cranio-caudal
direction. The following scanning parameters were used for
both 16-channel multi-detector CT scanners: detector conﬁgu-
rations of 16 · 0.75 mm, section thickness of 3.0 mm recon-
struction intervals of 1.5 mm for both scanners, table speedsTable 1 Grade A, C: the grade of contiguity of tumor with the adja
CA, celiac artery; CHA, common hepatic artery; PV, portal vein; SM
SMA CA
Grade A 15 20
Grade B < 50% Abutment 3 1
Grade C > 50% Encasement 1
Total 19 21of 17.0 mm per rotation, effective amperage settings of
200 mAs; rotation times of 0.5 s; tube voltage of 120 kVp;
and a matrix of 512 · 512.
3.2. Image analysis and surgical correlation
Pancreatic tumor relation to major peripancreatic vessels,
including celiac artery (CA); common hepatic artery (CHA);
superior mesenteric artery (SMA); portal vein (PV); and supe-
rior mesenteric vein (SMV), was determined preoperatively at
consensus reading of axial CT source images combined with
post-processed images by two radiologists using the following
criteria:
1. Contiguity of tumor with the adjacent vessel was graded A,
D based on that suggested by Li et al. (13) and the template
provided by Gottlieb et al. (14): Grade A, fat plane or nor-
mal pancreatic tissue visible between tumor and vessel;
Grade B (Abutment) and Grade C (Encasement), tumor sur-
rounding of less than and more than 50% of the vessel cir-
cumference respectively; Grade D, arterial embedment in
tumor or venous occlusion.
2. Detailed vascular anatomic deformation: vessel stenosis
presented a semi-circular or concentric smaller contour of
the vessel. A straight contour on one side was regarded as
ﬂattened, not as stenosis. Vessel wall inﬁltration presented
as irregular and indented shape at the vascular margin
abutting tumor.
At surgery, 179 out of 235 vessels were properly assessed,
the remaining 56 vessels were inadequately assessed either
due to deeply seated vessels or matting with adjacent struc-
tures. The surgical criterion of tumor ingrowth into the vessels
was that the vessel could be observed, or found by palpation to
be inﬁltrated or occluded at surgery. Easy separation of an
adherent vessel from its surrounding tissue during surgery
was a clinical sign of perivascular adhesion due to inﬂamma-
tory or ﬁbrotic reaction rather than tumor invasion.
An informed consent was taken from all patients before
performing the MDCT and surgery after explanation of the
procedures and their beneﬁts or potential hazards. All data
collected were coded to insure patient privacy.
3.3. Statistical analysis
Chi-square tests were performed on the difference between the
number of affected arteries and veins, and on the MDCT signs:
(a) vessels showing stenosis or occlusion; (b) vessels showing
wall irregularity; (c) tumor surrounding more than 50% of
the vessel circumference; to check for any signiﬁcant difference
between the invaded arteries and veins. A P value of <0.05cent (115) non-invaded vessels (SMA, superior mesenteric artery;
V, superior mesenteric vein).
CHA PV SMV Total
22 27 16 100
2 3 9
1 4 6
23 29 23 115
Table 2 The differences in the frequency of arterial and venous invasion on MDCT.
CT signs Artery Vein Chi2 p-Value
SMA CA CHA Total SMV PV Total
Vessel stenosis or occlusion 4/13 2/4 2/5 8/22 16/25 11/17 27/42 4.542 0.033
Vessel wall irregularity 7/13 2/4 2/5 11/22 18/22* 11/15* 29/37 5.09 0.024
Tumor contiguity > 50% of vessel circumference 12/13 4/4 5/5 21/22 12/22* 9/15* 21/37 10.073 0.002
* Five veins (3 SMVs, 2 PVs) totally occluded by tumors were not included.
A
B
Fig. 1 (A) Axial CT scan of the abdomen at the level of the
celiac artery in a patient with pancreatic body adenocarcinoma in
the arterial phase showing encasement of the celiac & common
hepatic arteries by the mass causing stenosis of its lumen. (B)
Sagittal thick slab MPR of the abdomen at the level of the celiac &
superior mesenteric arteries in the same patient showing encase-
ment of the celiac artery by the mass appearing as irregularity and
narrowing of its lumen (arrow).
A
B
Fig. 2 (A) Axial CT scan of the abdomen at the level of the
celiac artery in a patient with pancreatic body adenocarcinoma in
the arterial phase showing encasement of the celiac & common
hepatic arteries and its branches by the mass causing marked
narrowing and irregularity of their outlines. (B) Axial CT scan of
the abdomen at the level of the SMA artery in the same patient
with pancreatic body adenocarcinoma in the arterial phase
showing encasement of the SMA artery and its branches by the
mass causing near total occlusion of their lumens.
Assessment of vascular invasion 273was considered statistically signiﬁcance. Sensitivity and speci-
ﬁcity of the resectability based on the CT and operative ﬁnd-
ings were calculated. Statistical software used was Minitab
16 (Minitab Inc., USA).
4. Results
CT showed pancreatic masses in 82 patients and pancreatic
carcinoma was pathologically conﬁrmed by biopsy or ﬁne-nee-
dle aspiration. MDCT images of the 82 patients were all pro-
spectively evaluated for resectability: including vascular
invasion and the presence of metastatic disease. Forty-seven
patients were pre-operatively judged to be resectable or requir-
ing surgical bypass due to jaundice. The remaining 35 patients
deemed irresectable from the beginning and received chemo-
therapy or radiotherapy. The 47 candidates for surgery were
32 males and 15 females, with their age range between 45and 82 years old, mean 63.5 years. Fifteen patients underwent
pancreaticoduodenectomy, cases judged to be resectable, and
32 patients underwent palliative surgery. The time interval be-
tween MDCT examination and surgery was less than 2 weeks.
In 25 patients of the 47 who underwent surgery, their tu-
mors were located in the pancreatic head or uncinate process
and in the other 22 their tumors were located in the pancreatic
body or tail.
Thirteen patients out of the 15 with who underwent pan-
creaticoduodenectomy (resectable tumors), were correctly
diagnosed by MDCT preoperatively. Two were incorrectly
judged to be irresectable because MDCT had shown tumor in-
growth into the SMA (n= 1) & CHA (n= 1).
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gery or surgical exploration, 6 patients were incorrectly diag-
nosed as having resectable tumors, due to missing vessels
invasion in 4 cases and missed hepatic metastases in 2. Based
on the previous ﬁndings the sensitivity and speciﬁcity for tu-
mor resectability by MDCT are 84.2% and 88.2%
respectively.
Out of the 179 observed vessels (97 arteries & 82 veins), 115
vessels were found not to be invaded at surgery and 64 were
invaded (22 arteries & 42 veins).There was a statistically signif-
icant difference between the number of invaded arteries and
veins, Chi2 = 15.756 and p< 0.0001.
MDCT ﬁndings in non-invaded 115 vessels as regards their
relation to the tumor after surgical conﬁrmation are shown in
Table 1:
1. Grade A of contiguity of tumor with the adjacent vessel (fat
plane or normal pancreatic tissue preserved) (n= 100, 15
SMAs, 20 CAs, 22 CHAs, 16 SMVs and 27 PVs).
2. Grade B (Abutment) of contiguity of tumor with the adja-
cent vessel (<180) (n= 9, 3 SMAs, 1 CA, 3 SMVs, 2
PVs).
3. Grade C (Encasement) of contiguity of tumor with the
adjacent vessels (>180) (n= 6, 4 SMVs, 1 SMA, 1 CHA).A
C
Fig. 3 (A) Sagittal thick slab MPR image of a patient with pancreati
of SMV causing near total occlusion of its lumen by the mass.
adenocarcinoma in the portal venous phase showing the mass and its r
occlusion. (C) Axial image of the same patient with pancreatic aden
relation to the SMV which is hardly identiﬁed, note the clear planes aMDCT signs in the 64 vessels with proven tumor invasion,
with statistical analysis of the difference in the frequency of
ﬁndings between the arteries and veins are shown in Table 2.
Eight of the 22 of the invaded arteries, representing 36%,
appeared stenosed and 27 of the 42 invaded veins, representing
64%, appeared as stenosed or occluded (Fig. 1a and b). Seven
veins (4 SMVs, 3 PVs), which were surrounded less than 50%
of the vessel circumference by tumor, also appeared stenosed,
the difference between the stenosis of arteries & veins was sta-
tistically signiﬁcant with p= 0.033.
Twenty-nine of the 37 invaded veins, representing 78%
after exclusion of 5 occluded veins, appeared inﬁltrated with
an irregular wall. Three of the inﬁltrated veins (2 SMVs, 1
PV) showing irregular walls, were surrounded by less than
50% of the vessel circumference and were not stenosed
(Fig. 4a–c).
Eleven of 22 invaded arteries, representing 50%, appeared
inﬁltrated less often than the invaded veins, after exclusion
of 5 occluded veins, there was a statistically signiﬁcant differ-
ence between the frequency of inﬁltration of the arteries and
veins with p= 0.024. (Figs. 2a and b, 3a–c).
Twenty-one of 37 veins with invasion, representing 57%,
with exclusion of 5 occluded veins were surrounded by more
than 50% of the vessel circumference by tumor.B
c adenocarcinoma in the portal venous phase showing encasement
(B) Coronal MPR image of the same patient with pancreatic
elation to the SMV with loss of its proximal opaciﬁcation denoting
ocarcinoma in the portal venous phase showing the mass and its
round the SMA.
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surrounded by more than 50% of the vessel circumference by
tumor or were embedded in tumor.
Statistical analysis showed a signiﬁcant difference between
invaded arteries and veins utilizing circumferential involve-
ment of more than 50% of the vessel circumference by tumor
with p= 0.002.
As regards other MDCT appearances of arterial and ve-
nous invasion, 2 of 25 invaded SMVs, representing 8%, were
diagnosed correctly as they had a ‘‘teardrop’’ appearance in
the axial images. When invaded veins were highly stenosed
or occluded, 17% (7/42), multiple venous collaterals were seen.
In 4 cases out of 22 showing invaded arteries, representing
18%, the arteries appeared deformed and seemed to be
stretched or stiffened in three dimension reconstruction
images, such as Volume rendering (VR) (Fig. 1b).5. Discussion
Cancer pancreas is one of the most aggressive malignant tu-
mors and represents the fourth cause of death from cancer.
It is usually associated with poor prognosis, this is likely due
to the deep location of the pancreas in the abdomen with its
close relation to major vessels and the tendency of the tumor
for early local and distant spread (15).
According to Egorov et al. (16), the vascular involvement in
patients with pancreatic carcinoma ranges between 21% and
64%.A
C
Fig. 4 (A) Axial image of a patient with pancreatic adenocarcinoma
conﬂuence (arrow), note the clear planes around the CA. (B) Coronal M
the portal venous phase showing the relation of the mass to the PV wit
patient showed a deposit in its right lobe at segments VIII and V
adenocarcinoma in the portal venous phase showing extension of throRecently MDCT has become the most important and reli-
able imaging modality in assessing patients with pancreatic
adenocarcinoma. It plays an important role in diagnosis of
pancreatic malignancy regarding the localization, size, dissem-
ination and staging of the tumors (17).
Many criteria were postulated for unresectability of the
pancreatic cancer, however assessment of vascular invasion is
considered one of the most important parameters for resect-
ability in the absence of metastatic disease which precludes
resection (18).
Our ﬁndings were in agreement with Shokry et al. (19) who
stated that the CT signs of arterial and venous involvement in
pancreatic cancer are different, this is likely due to more thin
and less ﬂexible walls of the veins, so when the vein is involved
it tends to be irregular and narrowed. In the same way, venous
occlusion is more common than arterial occlusion.
In our study, we adopted the method of evaluation of the
signs of arterial and venous invasion separately, suggested by
Li et al. (13), and in agreement with their ﬁndings we found
that it improves the accuracy of reporting the degree of vascu-
lar invasion.
In this study, three major arteries, namely the celiac artery
(CA), superior mesenteric artery (SMA) and common hepatic
artery (CHA) were carefully analyzed as their inﬁltration is an
important criterion for unresectability. We agreed with Buchs
et al. (18) that the superior mesenteric vessels are the most fre-
quently involved vessels in pancreatic cancer due to their ana-
tomical location closely adjacent to the pancreas. Our results
showed that encasement of the SMA was seen in 12 patients,B
in the portal venous phase showing the mass invading the PV at its
PR image of the same patient with pancreatic adenocarcinoma in
h ﬁlling defect within its lumen representing tumor thrombus. The
. (C) Coronal MPR image of the same patient with pancreatic
mbus along the SMV (arrow).
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5 patients. Our ﬁndings are in agreement with those of Brugel
et al. (20) and Vargas et al. (21) that with cross-sectional imag-
ing, the relationship between the tumor and the superior mes-
enteric vessels can be assessed more accurately. We also agreed
with them in that combining axial source data with VR and
curved MPR images is the optimal method for evaluation of
unresectability.
On other hand, our statistics revealed that venous stenosis
and occlusion are more common than that of the adjacent
arteries. Twenty-seven of the 42 invaded veins, representing
64%, appeared as stenosed or occluded, in comparison to 8
out of the 22 invaded arteries representing 36% showed
signiﬁcant stenosis. However isolated Venous involvement is
not considered as contraindication for surgery by most of
pancreatic surgeons as mentioned by Li et al. (13). This is
because venous resections and reconstructions are increasingly
performed and the technique becomes more feasible and
reliable.
In the same way the arterial wall is more resistive to neo-
plastic inﬁltration than the venous wall, this is again due to
its more thickness and ﬂexibility. In our study vascular inﬁltra-
tion was seen more in involved veins (78%) than in involved
arteries (50%). Similar results were mentioned by Shokry
et al. (19).
The teardrop mesenteric vein sign was described by Li et al.
(22) as a speciﬁc sign of tumor involvement of the SMV. It
refers to a focally tethered SMV assuming a shape of a tear-
drop. This sign presumably results from either direct tumor
inﬁltration or peritumoral ﬁbrosis adherent to the vessel that
retracts or tethers the vessel, changing its normal round shape.
It was considered as sign of unresectability. In our study, there
were two invaded SMVs conﬁrmed by surgical exploration and
exhibiting the teardrop sign on axial images.
In our study, two arteries (one SMA, one CHA) were found
not to be invaded at surgical exploration, although they were
surrounded by more than 50% of the vessel circumference,
but their caliber remained unchanged and the walls were
regular.
Since pancreatic carcinoma may be accompanied by focal
tissue ﬁbrosis, the invaded arteries may appear stretched as
reported by Horton et al. (12). In our study, four stretched
arteries were appreciated on three-dimensional reconstruction
MDCT angiography (MDCTA) images.
The sensitivity and speciﬁcity of tumor resectability based
on MDCT ﬁndings in this study were 84.2% and 88.2%
respectively which are in agreement with those reported by
Morgan et al. (23)
A major limitation of our study is that our gold standard is
the surgical palpation, because irresectable tumors could not
be histologically assessed.6. Conclusion
In conclusion, the frequency of venous invasion by pancreatic
tumors is signiﬁcantly higher than arteries, and despite the
similarity in the MDCT signs of vascular invasion between
arteries and veins they are seen signiﬁcantly more in veins than
arteries. It is important to pay attention to these differences in
order to improve the accuracy of diagnosing vascular invasion
and pancreatic resectability.Conﬂict of interest
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